Monika Kutyna

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Deepak Singhal, Li Yan A. Wee, Monika Kutyna et al. · Leukemia · 2019 · 61 citations

Hematological Malignancy, Primary Myelodysplastic Syndrome, Mutational Burden +10

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome

Deepak Singhal, Monika Kutyna, Rakchha Chhetri et al. · Haematologica · 2017 · 58 citations · Full text

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability

Danièl Thomas, Manhong Wu, Yusuke Nakauchi et al. · Cancer Discovery · 2022 · 52 citations · Full text

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

Deepak Singhal, Christopher N Hahn, Simone Feurstein et al. · Leukemia · 2021 · 48 citations

Pathogenic Germline Variants, Gene Panels, Oncology +12

<i>TP53</i>mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Devendra Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran et al. · Blood · 2022 · 36 citations · Full text

Immunohematology, Cancer Pathology, Pathology +24